Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Stock Information | RedChip

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Listen to this Section


$5.17
+0.0500 ( +0.98% ) 825.0K

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

Market Data


Open


$5.17

Previous close


$5.12

Volume


825.0K

Market cap


$301.36M

Day range


$5.11 - $5.29

52 week range


$3.30 - $6.75

Insider Ownership Transactions

Total Amount Purchased: -136,424.00 | $ -705,312.08

Date Type Amount Purchased Purchaser
2024-07-29 Sale -2251.00 Moran Kevin Patrick
2024-05-24 Sale -21887.00 Chrousos Phaedra
2024-05-21 Sale -20529.00 Mitchell Stephen Ray
2024-05-21 Sale -20529.00 Ward Anne Sempowski
2024-05-21 Sale -20529.00 Honore Tage
2024-05-21 Sale -20529.00 DUGAN RICHARD W
2024-03-06 Sale -5798.00 Moran Kevin Patrick
2024-03-06 Sale -7498.00 Wijkstrom Joakim
2024-03-06 Sale -8147.00 Williams Timothy
2024-03-06 Sale -8727.00 Birznieks Gunther

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 81 Aug 01, 2024
8-k 8K-related 16 Jul 31, 2024
4 Insider transactions 1 Jul 29, 2024
8-k 8K-related 16 Jun 20, 2024
8-k 8K-related 16 Jun 13, 2024
8-k 8K-related 16 Jun 06, 2024
8-k/a 8K-related 14 May 24, 2024
8-k 8K-related 16 May 24, 2024
4 Insider transactions 1 May 24, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.